Draft genome sequence of Catenibacterium mistuoki isolated from the fecal sample of a melanoma patient with complete response to immunotherapy
A strain of Catenibacterium spp. was isolated from a fecal sample of a patient diagnosed with stage IV melanoma in December 2008. The patient began treatment with the immune checkpoint inhibitor pembrolizumab in May 2016 and has since exhibited a sustained complete response to the therapy.
Salvato in:
| Autore principale: | |
|---|---|
| Altri autori: | , , , , , , |
| Natura: | article |
| Lingua: | inglese |
| Pubblicazione: |
2025
|
| Soggetti: | |
| Accesso online: | https://hdl.handle.net/20.500.12008/54082 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi: Draft genome sequence of Catenibacterium mistuoki isolated from the fecal sample of a melanoma patient with complete response to immunotherapy
- TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy
- Salmonella-Induced Cell Death in Cancer Immunotherapy: What Lies Beneath?
- Experience with immunotherapy in malignant melanoma
- Complete genome sequence of Campylobacter fetus isolated from a sheep
- Complete genome sequence of campylobacter fetus isolated from a sheep.
- Draft genome sequences of 40 pathogenic Leptospira strains isolated from cattle in Uruguay.